Article Details
Retrieved on: 2018-04-19 07:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Two Sigma Investments</b> LP purchased a new stake in Achillion Pharmaceuticals (NASDAQ:ACHN) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,107,595 shares of the biopharmaceutical company's ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here